The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
Open accessAbstract
Increased expression of CD47 has been reported to enable cancer cells to evade phagocytosis by macrophages and to promote the cancer stem cell phenotype, but the molecular mechanisms regulating CD47 expression have not been determined. Here we report that hypoxia-inducible factor 1 (HIF-1) directly activates transcription of the CD47 gene in hypoxic breast cancer cells. Knockdown of HIF activity or CD47 expression increased the phagocytosis of breast cancer cells by bone marrow-derived macrophages. CD47 expression was increased in mammosphere cultures, which are enriched for cancer stem cells, and CD47 deficiency led to cancer stem cell depletion. Analysis of datasets derived from thousands of patients with breast cancer revealed that CD47 expression was correlated with HIF target gene expression and with patient mortality. Thus, CD47 expression contributes to the lethal breast cancer phenotype that is mediated by HIF-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“hypoxic tumor cells evade innate immune recognition through the up-regulation of CD47, a cell surface molecule that interacts with signal regulatory protein alpha (SIRP α) on the surface of macrophages to block phagocytosis”
From Hypoxic control of metastasis (2016) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
7 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedSamanta, D., Gilkes, D. M., Chaturvedi, P., Xiang, L., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421438111 · Cited by 460
Self-citationRetractedRETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
Self-citationRetractedZhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326
Self-citationRetractedRETRACTED: Collagen Prolyl Hydroxylases Are Essential for Breast Cancer Metastasis
Gilkes, D. M., Chaturvedi, P., Bajpai, S., Wong, C. C., Wei, H., Pitcairn, S., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3963 · Cited by 296
Self-citationRetractedProcollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis
Gilkes, D. M., Bajpai, S., Wong, C. C., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0629 · Cited by 252
Self-citationRetractedGilkes, D. M., Xiang, L., Lee, S. J., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321510111 · Cited by 184
Self-citationRetractedPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Cited by
Sorted by citations
Items 401–425 of 425
de Oliveira, K. G., Bång-Rudenstam, A., Beyer, S., Boukredine, A., Hugo Talbot, A., Governa, V., Johansson, M. C., Månsson, A.-S., Forsberg‐Nilsson, K., Bengzon, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26685951
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26663002
Zhuang, H., Zhang, Z., Chen, B., Tang, C., Chen, X., Tan, W., Yang, L., Xie, Z., Ma, X., Wang, Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590796
Wu, H., Wang, T., Liu, Y., Li, X., Xu, S., Wu, C., Zou, H., Cao, M., Jin, G., Lang, J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13339314
Zhuang, H., Zhang, Z., Chen, B., Tang, C., Chen, X., Tan, W., Yang, L., Xie, Z., Ma, X., Wang, Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590793
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26663008
Chen, X.-J., Guo, C.-H., Wang, Z.-C., Yang, Y., Pan, Y., Liang, J.-Y., Sun, M., Fan, L.-S., Liang, L., & Wang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26662990
Gao, H., Hu, C., Wu, Q., & Fang, Z.-Z. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150437
Clofibrate inhibits tumor immune escape by increasing macrophage phagocytosis
Wang, H., Wang, Y., Li, Y., Yu, H., Shi, J., & Hou, Y. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178825
Labrousse, G. (2016) · theses.fr (ABES) · doi:10.70675/88a3d193z31f1z4a68z944bz3d7f7316b069
Impact du ciblage du domaine de liaison de HIF-1α avec HIF-1β sur le paysage immunitaire du mélanome
Lequeux, A. (2020) · theses.fr (ABES) · doi:10.70675/a29d12dbz79c1z4d37za978z2e2319131c82
Analyse du rôle des protéines FAK et CD47 dans l'invasion tumorale du mélanome
Mousson, A. (2020) · theses.fr (ABES) · doi:10.70675/fe000e00ze698z4536za6b1z7b9986716e1f
Ciblage thérapeutique de ALK et de CD47 dans le lymphome anaplasique à grandes cellules ALK-positif
Veleanu, L. (2023) · theses.fr (ABES) · doi:10.70675/2837df51zc15bz4221zb82fzc9f2a9e1008a
CD47: a promising target for immunotherapy in relapsed/refractory malignant lymphoma
Xiong, S., Yue, N., Zhang, S. W., Xu, Y., Cao, J., Liu, X., & Wu, C. (2026) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2026.2661769
Ye, Q., Huang, Y., Tian, H., Tingting, Z., Zhou, L., Qin, S., Bentley, G. T., Huang, C., & Xie, K. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.176954
Emerging Nanoplatforms are Effective Against Tumor Hypoxia
Yu, Z., Shang, Y., He, W., Xia, X., & Zhou, L. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s615263
Yılmaz, B. S., Yılmaz, S. S., & Çelik, Z. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125343
Pal, E., Chakraborty, S., & Guha, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1861308
Tumor Progression, Parallel Mechanisms and Therapeutic Targets
Håkansson, L., Dunér, P., & Håkansson, A. (2026) · Cancers · doi:10.3390/cancers18152518
Li, Q., Poma, A. M., Tang, D., Vignali, P., Bruno, R., Macerola, E., Fuochi, B., & Ugolini, C. (2026) · Cancers · doi:10.3390/cancers18162614
Advanced Nanotechnology for Precision Theranostics of Cancer Stem Cells
Liang, F., Wu, G., Xu, J., Gao, X., Chen, C., & You, Q. (2026) · ACS Nano · doi:10.1021/acsnano.6c11742
Ju, M., Zhang, M., Ma, S., An, Y., Xiao, S., Xu, J., Li, N., Chen, Y., Wei, M., Wang, H., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.10.003
Lin, Y., & Zhao, Z. (2026) · Central European Journal of Immunology · doi:10.5114/ceji/217208
Asoglu, H., Asarkaya, E., Aykut, A., Dorukhan, C. G., Camadan, Y. A., Kıdı, M. M., Biter, S., Yaslıkaya, Ş., Asoğlu, R., Toyran, T., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219671
Metadata
- Authors
- Zhang, H., Lu, H., Xiang, L., Bullen, J. W., Zhang, C., Samanta, D., Gilkes, D. M., He, J., & Semenza, G. L.
- Affiliations
- Johns Hopkins University (US)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-10-28
- Volume
- 112
- Issue
- 45
- Pages
- E6215-23
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4653179
- OpenAlex
- W1853160207
- Cited by
- 420
- References
- 62
- Citations by year
- 2026: 22 · 2025: 33 · 2024: 62 · 2023: 46 · 2022: 57 · 2021: 48 · 2020: 52 · 2019: 29 · 2018: 31 · 2017: 17 · 2016: 21 · 2015: 1
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-09-25)
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society (122437-RP-12-090-01-COUN)
- U.S. Department of Defense (W81XWH-12-1-0464)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- HIF-1, CD47, breast cancer, phagocytosis evasion, macrophages, cancer stem cells, hypoxia, transcriptional regulation, mammospheres, patient mortality, prognostic factors
- MeSH terms
- Analysis of Variance, Breast Neoplasms, Female, Humans, Luciferases, Phagocytosis, Neoplastic Stem Cells, Immunoblotting, Gene Expression Regulation, Neoplastic, DNA Primers, Tumor Escape, RNA, Small Interfering, Cell Line, Tumor, Chromatin Immunoprecipitation, Hypoxia-Inducible Factor 1, CD47 Antigen, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
